-
Start Preamble
ACTION:
Notice of application.
DATES:
Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before September 3, 2019.
ADDRESSES:
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.
End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.33(a), this is notice that on March 5, 2019, Pisgah Laboratories, Inc., 3222 Old Hendersonville Highway, Pisgah Forest, North Carolina 28768 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:
Controlled substance Drug code Schedule Difenoxin 9168 I Diphenoxylate 9170 II Levorphanol 9220 II Meperidine intermediate-B 9233 II The company plans to manufacture the listed controlled substances in bulk for distribution to its customers.
Start SignatureDated: June 19, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-14028 Filed 7-1-19; 8:45 am]
BILLING CODE 4410-09-P
Document Information
- Published:
- 07/02/2019
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Action:
- Notice of application.
- Document Number:
- 2019-14028
- Dates:
- Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before September 3, 2019.
- Pages:
- 31622-31622 (1 pages)
- Docket Numbers:
- Docket No. DEA-392
- PDF File:
- 2019-14028.pdf